Cipla inks pact with Eli Lilly to produce, sell COVID-19 treatment drug
PTI, May 10, 2021, 10:59 AM IST
New Delhi: Drug major Cipla on Monday said it has inked a pact with US-based Eli Lilly and Company to manufacture and produce baricitinib in the country for the treatment of COVID-19.
The Mumbai-based company said it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly for baricitinib.
Baricitinib has already received a restricted emergency use approval by the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health, India, for use in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19 in hospitalised adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
This collaboration is a step further in the company”s efforts to enhance access to critical treatments for patients affected by the pandemic, Cipla said in a statement.
The company will leverage its extensive distribution footprint to make this therapy accessible to more patients and markets, it added.
“Through the pandemic, Cipla has been at the forefront of COVID care and our partnership with Lilly is a demonstration of our unwavering commitment to care towards patients impacted by COVID-19,” Cipla Ltd MD and Global CEO Umang Vohra noted.
Cipla had last year launched a generic version of antiviral drug remdesivir to treat COVID-19 patients. The drug firm had also introduced antibody detection kits for COVID-19 in the country under the brand name ”ELIFast” in partnership with KARWA Ltd, under the technology transfer from the Indian Council of Medical Research (ICMR).
Amid spiralling cases of COVID-19 in the country amid the second wave, drug firms have been collaborating to come out with drugs to treat the highly infectious disease.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Markets rebound in early trade amid global rally, buying in ICICI Bank and Reliance
Elon Musk in Beijing amid efforts to promote Tesla’s autonomous driving tech
Corporate earnings, US Fed interest rate decision to drive markets in holiday-shortened week: Analysts
Pune court asks police to probe bribery allegations against IT major Cognizant
Patanjali Foods to evaluate proposal to buy Patanjali Ayurved’s non-food business
MUST WATCH
Latest Additions
If voted to power, Congress will conduct caste, economic survey: Rahul Gandhi
Chitradurga: Murugha Math see surrenders before court
Thomas Cup: India seal quarterfinal berth with 5-0 win over England
‘Will PM still remain silent?’ Priyanka Gandhi slams BJP over Hassan ‘sex scandal’
Kharge authorised to decide Amethi, Raebareli candidates: Congress